跳到正文
ECA GMP News·AI 评分69

六位专家解答 QP 批放行时审计追踪复核与缺少变更理由的判定问题

Audit Trail Review by the QP / Dealing with a Lack of Justification

AI 导读

六位制药行业与检查机构专家针对现行 EU GMP Annex 11 的审计追踪要求作答,涵盖 QP 在批放行时如何核对屏幕上显示的审计追踪复核确认。专家表示,审计追踪复核须在 SOP 中规定,复核人应在一定程度上独立于业务流程,复核可纳入批记录审核,出现的差异须调查并处理。若系统能记录变更理由却未填写,即构成缺陷;系统不具备该功能时,可用 SOP 规定在日志中记录变更或删除。

正文 · 原文

The requirements for an audit trail can be found in all relevant regulations. The changes and deletions of data, and in future also the creation of data, should be tracked in this way. In the new draft of the EU GMP Guideline Annex 11, the requirements were described in much greater detail than before. 6 Experts from the pharmaceutical industry and from inspectorates answer an extensive list of questions in this context, focusing on the currently valid Annex 11. Question 6: Confirmation of the audit trail review takes place on screen. How does the QP check this during batch release, and is it required for release?Firstly, the audit trail review must be regulated in an SOP. The person conducting the review should be independent of the business process in some way. The review is documented. The review can be part of the batch record review.Discrepancies in audit trails must be investigated and resolved, including escalation processes for notification, who needs to be informed and when? The QP's assessment of the deviations is decisive for the release of a medicinal product. The product can then be released.Question 7: Is the absence of a comment (reason for a change) in the audit trail sufficient grounds for a complaint during an inspection?According to EU GMP Annex 11, the change or deletion must be justified. If the system is capable of doing this and no reason has been entered, this constitutes a deficiency. If the system is not capable of documenting the reason, a corresponding workaround is required. For systems without this functionality, an SOP can be used to regulate how changes or deletions are documented in a logbook.Find more Q&As on the topic 'Audit Trail' which have been answered by the expert team. The Expert Team:Klaus Feuerhelm, Local GMP Inspectorate / Regierungspräsidium TübingenEberhard Kwiatkowski, PharmAdvantageIT, NeuschooDr Ullrich Opitz, Merck, DarmstadtYves Samson, Kereon, BaselDr Wolfgang Schumacher, ehem. F. Hoffmann-La Roche, BaselDr Arno Terhechte, Local GMP Inspectorate / Bezirksregierung Münster

来源:ECA GMP News · gmp-compliance.org